US Patent 7189851 Condensed heterocyclic compounds as calcitonin agonists
Patent 7189851 was granted and assigned to Smithkline Beecham Limited on March, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+179 characters)
Article
Patent abstract
The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07189851 Condensed heterocyclic compounds as calcitonin agonists US Patent 7189851 Condensed heterocyclic compounds as calcitonin agonists
Infobox
Patent Number
0718985100
Patent Number
718985100
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071898510
Date of Patent
March 13, 2007
0Patent Application Number
105070060
Date Filed
February 24, 2003
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071898510
Date of Patent
March 13, 2007
0Patent Application Number
105070060
Date Filed
February 24, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07189851 Condensed heterocyclic compounds as calcitonin agonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07189851
Date of patent
March 13, 2007
Patent application number
10507006
Date Filed
February 24, 2003
Patent primary examiner
Find more entities like US Patent 7189851 Condensed heterocyclic compounds as calcitonin agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.